Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review. | Viruses | 2023 | 37632074 | PubTator, text mining | PubMed |
| Machine Learning Techniques Applied to the Study of Drug Transporters. | Molecules | 2023 | 37630188 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality. | Life (Basel) | 2023 | 37629602 | PubTator, text mining | PubMed |
| Identification of Novel Intronic SNPs in Transporter Genes Associated with Metformin Side Effects. | Genes (Basel) | 2023 | 37628660 | PubTator, text mining | PubMed |
| A Role for Genetic Modifiers in Tubulointerstitial Kidney Diseases. | Genes (Basel) | 2023 | 37628633 | PubTator, text mining | PubMed |
| SLC22A3 rs2048327 Polymorphism Is Associated with Diabetic Retinopathy in Caucasians with Type 2 Diabetes Mellitus. | Biomedicines | 2023 | 37626799 | PubTator, text mining | PubMed |
| Towards Evidence-Based Implementation of Pharmacogenomics in Southern Africa: Comorbidities and Polypharmacy Profiles across Diseases. | J Pers Med | 2023 | 37623436 | PubTator, text mining | PubMed |
| Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma. | Funct Integr Genomics | 2023 | 37610668 | PubTator, text mining | PubMed |
| Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies. | Pharmacol Rep | 2023 | 37605102 | PubTator, text mining | PubMed |
| New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System. | CNS Drugs | 2023 | 37603262 | PubTator, text mining | PubMed |
| Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer. | NPJ Breast Cancer | 2023 | 37598278 | PubTator, text mining | PubMed |
| Interactions of organophosphate flame retardants with human drug transporters. | Ecotoxicol Environ Saf | 2023 | 37597291 | PubTator, text mining | PubMed |
| In vivo Metabolism of Nifurtimox and the Drug-Drug Interaction Potential Including its Major Metabolites. | Curr Drug Metab | 2023 | 37592798 | PubTator, text mining | PubMed |
| Discovering metabolic vulnerability using spatially resolved metabolomics for antitumor small molecule-drug conjugates development as a precise cancer therapy strategy. | J Pharm Anal | 2023 | 37577390 | PubTator, text mining | PubMed |
| Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity. | Pharm Res | 2023 | 37561322 | PubTator, text mining | PubMed |
| Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis. | Front Public Health | 2023 | 37546319 | PubTator, text mining | PubMed |
| A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions. | Clin Pharmacol Ther | 2023 | 37540045 | PubTator, text mining | PubMed |
| Site-specific detection of circulating tumor DNA methylation in biological samples utilizing phosphorothioated primer-based loop-mediated isothermal amplification. | Biosens Bioelectron | 2023 | 37517335 | PubTator, text mining | PubMed |
| Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus. | Clin Proteomics | 2023 | 37516862 | PubTator, text mining | PubMed |
| L-Carnitine Suppresses Transient Receptor Potential Vanilloid Type 1 Activation in Human Corneal Epithelial Cells. | Int J Mol Sci | 2023 | 37511574 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=11